# MDMA Assisted Therapy for BN

> **NCT07542145** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 40 (estimated)

## Conditions studied

- Bulimia Nervosa

## Interventions

- **DRUG:** MDMA-AT
- **DRUG:** MDMA-AT-BN
- **BEHAVIORAL:** Standard Treatment (ST)

## Key facts

- **NCT ID:** NCT07542145
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2028-04-30
- **Final completion:** 2028-04-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07542145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07542145, "MDMA Assisted Therapy for BN". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07542145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*